These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 20211634)

  • 21. RNA and DNA aptamers in cytomics analysis.
    Ulrich H; Martins AH; Pesquero JB
    Cytometry A; 2004 Jun; 59(2):220-31. PubMed ID: 15170601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-based generation of viable leads from small combinatorial libraries.
    Laird ER; Blake JF
    Curr Opin Drug Discov Devel; 2004 May; 7(3):354-9. PubMed ID: 15216940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemical feature-based pharmacophores and virtual library screening for discovery of new leads.
    Langer T; Krovat EM
    Curr Opin Drug Discov Devel; 2003 May; 6(3):370-6. PubMed ID: 12833670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complex target SELEX.
    Shamah SM; Healy JM; Cload ST
    Acc Chem Res; 2008 Jan; 41(1):130-8. PubMed ID: 18193823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combining SELEX and the yeast three-hybrid system for in vivo selection and classification of RNA aptamers.
    König J; Julius C; Baumann S; Homann M; Göringer HU; Feldbrügge M
    RNA; 2007 Apr; 13(4):614-22. PubMed ID: 17283213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent trends in library design: 'rational design' revisited.
    Schnur DM
    Curr Opin Drug Discov Devel; 2008 May; 11(3):375-80. PubMed ID: 18428091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of peptide ligands for malignancy- and growth-regulating galectins using random phage-display and designed combinatorial peptide libraries.
    André S; Arnusch CJ; Kuwabara I; Russwurm R; Kaltner H; Gabius HJ; Pieters RJ
    Bioorg Med Chem; 2005 Jan; 13(2):563-73. PubMed ID: 15598577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Similarity metrics for ligands reflecting the similarity of the target proteins.
    Schuffenhauer A; Floersheim P; Acklin P; Jacoby E
    J Chem Inf Comput Sci; 2003; 43(2):391-405. PubMed ID: 12653501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polypeptide aptamer selection using a stabilized ribosome display.
    Wang W; Hara S; Liu M; Aigaki T; Shimizu S; Ito Y
    J Biosci Bioeng; 2011 Nov; 112(5):515-7. PubMed ID: 21813322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lead optimization via high-throughput molecular docking.
    Joseph-McCarthy D; Baber JC; Feyfant E; Thompson DC; Humblet C
    Curr Opin Drug Discov Devel; 2007 May; 10(3):264-74. PubMed ID: 17554852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A general technique to rank protein-ligand binding affinities and determine allosteric versus direct binding site competition in compound mixtures.
    Annis DA; Nazef N; Chuang CC; Scott MP; Nash HM
    J Am Chem Soc; 2004 Dec; 126(47):15495-503. PubMed ID: 15563178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrated microfluidic system for rapid screening of CRP aptamers utilizing systematic evolution of ligands by exponential enrichment (SELEX).
    Huang CJ; Lin HI; Shiesh SC; Lee GB
    Biosens Bioelectron; 2010 Mar; 25(7):1761-6. PubMed ID: 20061133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ligand-based approach to in silico pharmacology: nuclear receptor profiling.
    Mestres J; Martín-Couce L; Gregori-Puigjané E; Cases M; Boyer S
    J Chem Inf Model; 2006; 46(6):2725-36. PubMed ID: 17125212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The affinity concept in bioseparation: evolving paradigms and expanding range of applications.
    Mondal K; Gupta MN
    Biomol Eng; 2006 Jun; 23(2-3):59-76. PubMed ID: 16527537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.
    Rothe C; Urlinger S; Löhning C; Prassler J; Stark Y; Jäger U; Hubner B; Bardroff M; Pradel I; Boss M; Bittlingmaier R; Bataa T; Frisch C; Brocks B; Honegger A; Urban M
    J Mol Biol; 2008 Feb; 376(4):1182-200. PubMed ID: 18191144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel 2D fingerprints for ligand-based virtual screening.
    Ewing T; Baber JC; Feher M
    J Chem Inf Model; 2006; 46(6):2423-31. PubMed ID: 17125184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro selection of protein and peptide libraries using mRNA display.
    Takahashi TT; Roberts RW
    Methods Mol Biol; 2009; 535():293-314. PubMed ID: 19377989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative modeling and data analysis of SELEX experiments.
    Djordjevic M; Sengupta AM
    Phys Biol; 2005 Dec; 3(1):13-28. PubMed ID: 16582458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Scaffold composition and biological relevance of screening libraries.
    Shelat AA; Guy RK
    Nat Chem Biol; 2007 Aug; 3(8):442-6. PubMed ID: 17637770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening phage-displayed combinatorial peptide libraries.
    Kay BK; Kasanov J; Yamabhai M
    Methods; 2001 Jul; 24(3):240-6. PubMed ID: 11403573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.